Invenra to Present Preclinical Data on INV322, A Next Generation Tumor Treg Depleter
Exelixis and Invenra Expand Collaboration to Discover and Develop Novel Biologics in Oncology
Invenra Announces Expansion of Collaboration with Exelixis
